Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO)

P Peiyuan Wang Y Yujie Chen F Feng Wang M Mingqiu Chen B Buhong Zheng D Derong Zhang Q Qingfeng Zheng J Jiezhong Wang J Junqiang Chen H Huaxin Cai J Junhua Liu W Wenshan Zhang C Changhong Lian J Juhui Chen Y Yu Lin Y Yuanji Xu (Institute for Applied Physics) R Rongfang Huang M Mengxia Lei P Peng Chen H Hao He H Hui Lin X Xiaofeng Chen (School of Chemical Engineering) H Hang Zhou W Weijie Chen (Laboratory of Advanced Optoelectronic Materials, Suzhou Key Laboratory of Novel Semiconductor-optoelectronics Materials and Devices, State Key Laboratory of Bioinspired Interfacial Materials Science, College of Chemistry, Chemical Engineering and Materials Science) W Wenwei Wei F Fengnian Zhuang J Junpeng Lin C Canhua Huang N Ni Guan J Jin Yan (Shanghai Key Laboratory of Green Chemistry and Chemical Processes, School of Chemistry and Molecular Engineering) S Shujun Liang S Shuoyan Liu J Jiancheng Li (Department of Chemistry, College of Science)